Rifka Kats
Member of Macroaxis Editorial Board
Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
Company Analysis | |
achuva@macroaxis.com | |
Rifka Kats Latest Stories - Published
January often brings a fresh start, and for investors, it can signal a time to reassess portfolios and consider new opportunities. Celularity, a biotechnology firm trading under the ticker CELU on NASDAQ, may catch the eye of savvy investors looking for potential rebounds. Despite a challenging previous quarter with a net income from continuing operations at **$14.2M** and a quarterly earnings growth of -0.93, the company's enterprise value stands at a notable **$101.2M**.
| a day ago at Macroaxis By Rifka Kats |  |
The average rating for Greenlane Holdings is 'Hold', as determined by one analyst. We offer advice to supplement the standard expert consensus on Greenlane Holdings. Our sophisticated recommendation engine employs a multidimensional algorithm to assess the company's growth potential, using all available technical and fundamental data at the time.
Main Takeaways
Greenlane Holdings (NASDAQ: GNLN) has been under the radar for many investors, but recent data suggests it may be worth a closer look.| over a week ago at Macroaxis By Rifka Kats | |
Buy low, sell high. That's the age-old adage in investing. However, for Aesthetic Medical International (AIH), a player in the Healthcare sector specifically under Health Care Providers & Services, it might be time to reconsider this principle.
| over a week ago at Macroaxis By Rifka Kats | |
In the world of healthcare equipment and supplies, the potential for exponential growth often lies in the hands of innovative companies like Check Cap. This NASDAQ-listed firm, known for its unique diagnostic solutions, has been showing promising signs of a potential growth spurt. With a beta of 0.617, the stock demonstrates less volatility than the market, making it a potentially safer bet in turbulent times.
| over a week ago at Macroaxis By Rifka Kats | |
Every cloud has a silver lining, and for Yirendai (USA Stocks: YRD), a leading player in the Credit Services industry, the prospects look promising as we approach the end of the year. Despite a challenging year marked by a net interest income loss of $26.3M, the company has shown resilience, with a net income from continuing operations of a whopping $1.2B. The company's stock, listed on the NYSE, has been showing signs of a potential bullish surge this December.
| over a week ago at Macroaxis By Rifka Kats | |
Kellanova, a prominent player in the Packaged Foods industry, showed significant market strength today with its stock making robust gains. The company's financial health is supported by a healthy Ebitda of $1.9B and Net Income From Continuing Ops of $962M. Although the company had a Dividends Paid loss of $797M, the Last Dividend Paid was $2.36, indicating a consistent return to shareholders.
| over three weeks ago at Macroaxis By Rifka Kats | |
Bluegreen Vacations (BVH) has recently seen a surge in its stock price, and a look at its fundamental indicators suggests that this trend may continue. The company's net income stands at a healthy $81.25M, indicating strong profitability. This is further supported by a profit margin of 0.06%, which, while modest, is a positive sign.
| over three weeks ago at Macroaxis By Rifka Kats | |
By examining the fundamental indicators between Wrap Technologies and Sensata, we can assess the impact of market volatility on the prices of both companies. This analysis can also help determine if combining these companies in a single portfolio can help diversify market risk. Pair trading strategies can also be employed, such as matching a long position in Sensata with a short position in Wrap Technologies.
| over three weeks ago at Macroaxis By Rifka Kats | |
Every cloud has a silver lining, and this seems to be the case for Miromatrix Medical (NASDAQ: MIRO), a company operating in the Biotechnology industry. Despite reporting a loss of 30 million in Net Income From Continuing Ops and Operating Income, the company's shares have been on a bullish trend, showing signs of significant resilience. The company, which debuted on the NASDAQ on the 24th of June 2021, has seen its shares experience a 52 Week High of 4.5, while its 52 Week Low was registered at 0.9065.
| over three weeks ago at Macroaxis By Rifka Kats | |
AZZ Inc. (NYSE: AZZ), a leading player in the industrials sector, specifically heavy electrical equipment, presents a compelling investment opportunity. As of the latest update on October 10, 2023, the company has shown promising signs of growth and stability. The company's EPS estimate for the current year stands at $4.09, while the EPS estimate for the next year is projected at $3.92.
| over a month ago at Macroaxis By Rifka Kats | |
Latest Stories
Recently Published Macroaxis Headlines
